1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors

Details for Australian Patent Application No. 2005210114 (hide)

Owner Nerviano Medical Sciences S.r.l.

Inventors Tesei, Dania; Vioglio, Sergio; Varasi, Mario; Bindi, Simona; Vianello, Paola; Fancelli, Daniele

Agent Davies Collison Cave

Pub. Number AU-B-2005210114

PCT Pub. Number WO2005/074922

Priority 60/541,452 03.02.04 US

Filing date 2 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 14 July 2011

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/074922 Priority application(s): WO2005/074922

24 February 2011 Assignment before Grant

  Pfizer Italia S.r.l. The application has been assigned to Nerviano Medical Sciences S.r.l.

14 July 2011 Application Accepted

  Published as AU-B-2005210114

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210117-Hypocholesterolemic compositions comprising a statin and an antiflatulent agent

2005210106-Combined use of PRAME inhibitors and HDAC inhibitors